These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

69 related articles for article (PubMed ID: 25222975)

  • 1. [Fructose as a risk factor nonalcoholic fatty liver disease].
    Yi C; Li Y
    Zhonghua Gan Zang Bing Za Zhi; 2014 May; 22(5):383-5. PubMed ID: 25222975
    [No Abstract]   [Full Text] [Related]  

  • 2. Fructose and Nonalcoholic Fatty Liver Disease.
    Lustig RH
    J Calif Dent Assoc; 2016 Oct; 44(10):613-17. PubMed ID: 29035477
    [No Abstract]   [Full Text] [Related]  

  • 3. [Development and evaluation of a high-fat/high-fructose diet-induced nonalcoholic steatohepatitis mouse model].
    Liu J; Liu Y; Wang W; Luo Y; Zhuang Z; Jiao Q; Chen J; Bian D; Ma X; Xun Y; Zhu M; Shi J
    Zhonghua Gan Zang Bing Za Zhi; 2014 Jun; 22(6):445-50. PubMed ID: 25203709
    [TBL] [Abstract][Full Text] [Related]  

  • 4. PNPLA3: A Determinant of Response to Low-Fructose Diet in Nonalcoholic Fatty Liver Disease.
    McGeoch LJ; Patel PR; Mann JP
    Gastroenterology; 2018 Mar; 154(4):1207-1208. PubMed ID: 29452087
    [No Abstract]   [Full Text] [Related]  

  • 5. [Strengthen researches on risk factors and early diagnosis of nonalcoholic fatty liver].
    Li YM
    Zhonghua Gan Zang Bing Za Zhi; 2013 Nov; 21(11):805-7. PubMed ID: 24516924
    [No Abstract]   [Full Text] [Related]  

  • 6. KHK inhibition for the treatment of hereditary fructose intolerance and nonalcoholic fatty liver disease: a double-edged sword.
    Pinheiro FC; Sperb-Ludwig F; Schwartz IVD
    Cell Mol Life Sci; 2020 Sep; 77(17):3465-3466. PubMed ID: 32591859
    [No Abstract]   [Full Text] [Related]  

  • 7. Dietary fructose and intestinal barrier: potential risk factor in the pathogenesis of nonalcoholic fatty liver disease.
    Spruss A; Bergheim I
    J Nutr Biochem; 2009 Sep; 20(9):657-62. PubMed ID: 19679262
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Relationship between normal serum uric acid levels and nonalcoholic fatty liver disease in postmenopausal women].
    Liu P; Ma F; Lou H; Zhu Y; Chen Y
    Zhonghua Gan Zang Bing Za Zhi; 2014 Jan; 22(1):53-7. PubMed ID: 24721245
    [TBL] [Abstract][Full Text] [Related]  

  • 9. SREBP-1c in nonalcoholic fatty liver disease induced by Western-type high-fat diet plus fructose in rats.
    Aragno M; Tomasinelli CE; Vercellinatto I; Catalano MG; Collino M; Fantozzi R; Danni O; Boccuzzi G
    Free Radic Biol Med; 2009 Oct; 47(7):1067-74. PubMed ID: 19616615
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Prevalence of nonalcoholic fatty liver disease in Asia].
    Zhang W; Wei L
    Zhonghua Gan Zang Bing Za Zhi; 2013 Nov; 21(11):801-4. PubMed ID: 24516923
    [No Abstract]   [Full Text] [Related]  

  • 11. [Drugs clinical trials of nonalcoholic fatty liver disease: the present and future].
    Mao YM
    Zhonghua Gan Zang Bing Za Zhi; 2013 Nov; 21(11):808-10. PubMed ID: 24516925
    [No Abstract]   [Full Text] [Related]  

  • 12. Carbohydrate intake and nonalcoholic fatty liver disease.
    Neuschwander-Tetri BA
    Curr Opin Clin Nutr Metab Care; 2013 Jul; 16(4):446-52. PubMed ID: 23657151
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Dietary fructose in nonalcoholic fatty liver disease.
    Vos MB; Lavine JE
    Hepatology; 2013 Jun; 57(6):2525-31. PubMed ID: 23390127
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Current status of gut microbiota and metagenome with nonalcoholic fatty liver disease].
    Shen F; Fan JG
    Zhonghua Gan Zang Bing Za Zhi; 2013 Nov; 21(11):811-4. PubMed ID: 24516926
    [No Abstract]   [Full Text] [Related]  

  • 15. [Analysis of metabolic risk factors for developing nonalcoholic fatty liver in patients with type 2 diabetes mellitus].
    Guo M; Xi G; Yang N; Yao H
    Zhonghua Gan Zang Bing Za Zhi; 2014 Aug; 22(8):631-5. PubMed ID: 25243967
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A 4-polymorphism risk score predicts steatohepatitis in children with nonalcoholic fatty liver disease.
    Nobili V; Donati B; Panera N; Vongsakulyanon A; Alisi A; Dallapiccola B; Valenti L
    J Pediatr Gastroenterol Nutr; 2014 May; 58(5):632-6. PubMed ID: 24345846
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Role of tumor necrosis factor α (TNFα) in the onset of fructose-induced nonalcoholic fatty liver disease in mice.
    Kanuri G; Spruss A; Wagnerberger S; Bischoff SC; Bergheim I
    J Nutr Biochem; 2011 Jun; 22(6):527-34. PubMed ID: 20801629
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Does fructose consumption contribute to non-alcoholic fatty liver disease?
    Tappy L; Lê KA
    Clin Res Hepatol Gastroenterol; 2012 Dec; 36(6):554-60. PubMed ID: 22795319
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [[Current approaches to diagnosing and treating nonalcoholic fatty liver disease].
    Drapkina OM; Deeva TA; Volkova NP; Ivashkin VT
    Ter Arkh; 2014; 86(10):116-23. PubMed ID: 25509904
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pathological features of fatty liver disease.
    Yeh MM; Brunt EM
    Gastroenterology; 2014 Oct; 147(4):754-64. PubMed ID: 25109884
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.